Balda AG / Key word(s): Statement/Miscellaneous
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP – a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
Bad Oeynhausen, June 13, 2008. The talks of Balda AG with banks and several
investors about a reorganization of its financing structure will continue
in the weeks ahead, in particular with respect to the redemption of its
syndicated loan and promissory notes creditors.
Besides the existing offers for the redemption of the banks, in which Balda
AG participated, ‘the banks under certain conditions will also consider a
prolongation of their exposure’, according to Balda CEO Joachim Gut. The
Balda board is convinced that the agreement not to call loans will be
extended sufficiently to be able to successfully complete the negotiations
about the refinancing within this time-frame.
After the sale of its European infocom production sites, the Balda group is
primarily in a strong position in the important growth markets China and
India and owns four production facilities in the region. Plants in Brazil
and in Malaysia, as well as the facility in Germany for Balda Medical,
underline the global competitiveness of the group of companies. The major
part of its financing, however, is carried by banks traditionally still
domiciled in Germany. The future financing structure is to reflect the
strategic and geographic focus of the group adequately.
Balda will publish its half-year results on August 6. The annual meeting
takes place on July 29 in Bielefeld.
* * *
Company profile Balda AG
The internationally operating Balda Group develops and produces highly
integrated devices comprising plastic, metal and electronic components as
well as touch sensors. Among the customers of the SDAX listed company are
international brand-names from the mobile telephony industry, medical
technology and various related markets.
The integration of plastic and touch screen technologies creates completely
new customer benefits. Only Balda currently offers both technologies from
one source on a global scale. The group has a strong position in the
important growth markets China and India and owns four production
facilities in the region. Plants in Brazil and in Malaysia, as well as the
facility in Germany for Balda Medical, underline the global competitiveness
of the group of companies.
* * *
Information and Explaination of the Issuer to this News:
This ad hoc-announcement includes ‘forward-looking statements’ which are
based on the current expectations of the management of Balda. They are
subject to risks and uncertainty because they relate to events and depend
on circumstances that will occur in the future, such as, for example,
developments in the mobile communications industry, changes in technology
and the ability to timely and successfully develop new products and various
other factors. Balda does not undertake any obligation to update publicly
or revise forward-looking statements except to the extent legally required.
This ad hoc-announcement is not an offer of securities for sale or a
solicitation of an offer to purchase securities in the United States or
elsewhere. The shares in Balda AG (the ‘Shares’) may not be offered or sold
in the United States or to or for the account or benefit of U.S. persons
(as such term is defined in Regulation S under the U.S. Securities Act of
1933, as amended (the ‘Securities Act’)) unless registered under the
Securities Act or pursuant to an exemption from such registration. The
Shares have not been and will not be registered under the Securities Act.
* * *
* * *
If you have any questions please contact: Balda AG, Clas Röhl, Phone: +49
5734 922 2728, Fax: +49 5734 922 2691, Mail: firstname.lastname@example.org, Internet:
* * *
13.06.2008 DGAP’s Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Company: Balda AG
Bergkirchener Str. 228
32549 Bad Oeynhausen
Phone: +49 (0) 57 34 / 9 22-0
Fax: +49 (0) 57 34 / 9 22-2604
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart
End of Announcement DGAP News-Service